Smoking, alcohol, and coffee consumption preceding Parkinson’s disease: A case-control study
Abstract
OBJECTIVE: To study the association of PD with preceding smoking, alcohol, and coffee consumption using a case-control design. METHODS: The authors used the medical records linkage system of the Rochester Epidemiology Project to identify 196 subjects who developed PD in Olmsted County, MN, during the years 1976 to 1995. Each incident case was matched by age (+/-1 year) and sex to a general population control subject. The authors reviewed the complete medical records of cases and control subjects to abstract exposure information. RESULTS: For coffee consumption, the authors found an OR of 0.35 (95% CI = 0.16 to 0.78, p = 0.01), a dose-effect trend (p = 0.003), and a later age at PD onset in cases who drank coffee compared with those who never did (median 72 versus 64 years; p = 0.0002). The inverse association with coffee remained significant after adjustment for education, smoking, and alcohol drinking and was restricted to PD cases with onset at age <72 years and to men. The OR for cigarette smoking was 0.69 (95% CI = 0.45 to 1.08, p = 0.1). The authors found no association between PD and alcohol consumption. Extreme or unusual behaviors such as tobacco chewing or snuff use and a diagnosis of alcoholism were significantly more common in control subjects than cases. CONCLUSIONS: These findings suggest an inverse association between coffee drinking and PD; however, this association does not imply that coffee has a direct protective effect against PD. Alternative explanations for the association should be considered.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Caffeine overdose can delay sleep onset, reduce total sleep time, change normal sleep stages, and reduce sleep quality.
“Caffeine overdose can delay sleep onset, reduce total sleep time, change normal sleep stages, and reduce sleep quality. Caffeine-induced sleep disorder is known as a psychiatric disorder caused by excessive caffeine consumption [120].”
From Effect of Caffeine Consumption on the Risk for Neurological and Psychiatric Disorders: Sex Differences in Human (2020) · cites this paper as [120]
Excessive caffeine can cause symptoms ranging from general anxiety to compulsive disorders.
“Excessive caffeine can cause symptoms ranging from general anxiety to compulsive disorders [120].”
From Effect of Caffeine Consumption on the Risk for Neurological and Psychiatric Disorders: Sex Differences in Human (2020) · cites this paper as [120]
Cites
A Systematic Method for Clinical Description and Classification of Personality Variants: A Proposal
Cloninger, C. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800180093014 · Cited by 3,678 · see citing works
Sackett, D. L. (1979) · Journal of Chronic Diseases · doi:10.1016/0021-9681(79)90012-2 · Cited by 2,075 · see citing works
History of the Rochester Epidemiology Project
Melton, L. J. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.3.266 · Cited by 1,443 · see citing works
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor
Ledent, C. A., Vaugeois, J., Schiffmann, S. N., Pedrazzini, T., Yacoubi, M. E., Vanderhaeghen, J. J., Costentin, J., Heath, J. K., Vassart, G., & Parmentier, M. (1997) · Nature · doi:10.1038/41771 · Cited by 918 · see citing works
Tanner, C. M., Ottman, R., Goldman, S. M., Ellenberg, J., Chan, P., Mayeux, R. P., & Langston, J. W. (1999) · JAMA · doi:10.1001/jama.281.4.341 · Cited by 869 · see citing works
The Patient Record in Epidemiology
Kurland, L. T., & Molgaard, C. A. (1981) · Scientific American · doi:10.1038/scientificamerican1081-54 · Cited by 789 · see citing works
Association of coffee and caffeine intake with the risk of Parkinson disease
Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778 · see citing works
Ferré, S., von Euler, G., Johansson, B., Fredholm, B. B., & Fuxé, K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7238 · Cited by 551 · see citing works
Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990
Bower, J. H., Maraganore, D. M., McDonnell, S. K., & Rocca, W. A. (1999) · Neurology · doi:10.1212/wnl.52.6.1214 · Cited by 509 · see citing works
Cigarette smoking and protection from Parkinson's disease
Morens, D. M., Grandinetti, A., REED, D. M., White, L. R., & Ross, G. W. (1995) · Neurology · doi:10.1212/wnl.45.6.1041 · Cited by 368 · see citing works
Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease
Richardson, P. J., Kase, H., & Jenner, P. G. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01096-1 · Cited by 262 · see citing works
Dopamine‐related personality traits in Parkinson's disease
Menza, M. A., Golbe, L. I., Cody, R., & Forman, N. (1993) · Neurology · doi:10.1212/wnl.43.3_part_1.505 · Cited by 247 · see citing works
Howard, M. O., Kivlahan, D. R., & Walker, R. D. (1997) · Journal of Studies on Alcohol · doi:10.15288/jsa.1997.58.48 · Cited by 244 · see citing works
Prospective Study of Cigarette Smoking and the Risk of Developing Idiopathic Parkinson's Disease
Grandinetti, A., Morens, D. M., REED, D. M., & MacEachern, D. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116960 · Cited by 221 · see citing works
Diet and Parkinson's disease II
Hellenbrand, W., Boeing, H., Robra, B., Seidler, A., Vieregge, P., NISCHAN, P., Joerg, J., Oertel, W. H., Schneider, E., & Ulm, G. (1996) · Neurology · doi:10.1212/wnl.47.3.644 · Cited by 195 · see citing works
Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious
Baron, J. A. (1996) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011533 · Cited by 190 · see citing works
Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease
Pappert, E. J., Goetz, C. G., Niederman, F. G., Raman, R., & Leurgans, S. E. (1999) · Movement Disorders · doi:10.1002/1531-8257(199901)14:1 · Cited by 180 · see citing works
Smoking and Parkinson's disease.
Godwin-Austen, R. B., Lee, P. N., Marmot, M. G., & Stern, G. M. (1982) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.45.7.577 · Cited by 179 · see citing works
Rajput, A. H., Offord, K. P., Beard, C. M., & Kurland, L. T. (1987) · Neurology · doi:10.1212/wnl.37.2.226 · Cited by 144 · see citing works
Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease
Richardson, P. J., Kase, H., & Jenner, P. G. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)90660-x · Cited by 136 · see citing works
The pre-morbid personality of patients with Parkinson's disease.
Todes, C., & Lees, A. J. (1985) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.2.97 · Cited by 135 · see citing works
A RETROSPECTIVE STUDY OF SMOKING IN PARKINSON'S DISEASE1
Nefzger, M. D., QUADFASEL, F. A., & KARL, V. C. (1968) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120874 · Cited by 130 · see citing works
Diet and Parkinson's disease I
Hellenbrand, W., Seidler, A., Boeing, H., Robra, B., Vieregge, P., NISCHAN, P., Joerg, J., Oertel, W. H., Schneider, E., & Ulm, G. (1996) · Neurology · doi:10.1212/wnl.47.3.636 · Cited by 119 · see citing works
Abnormal performance on the PD test battery by asymptomatic first-degree relatives
Montgomery, E. B., Baker, K. B., Lyons, K., & Koller, W. C. (1999) · Neurology · doi:10.1212/wnl.52.4.757 · Cited by 89 · see citing works
NICOTINE EXPOSURE AND PARKINSON DISEASE
Haack, D. G., Baumann, R. J., McKean, H. E., Jameson, H. D., & Turbek, J. A. (1981) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113182 · Cited by 75 · see citing works
Is there a premorbid personality typical for Parkinson's disease?
Paulson, G. W., & Dadmehr, N. (1991) · Neurology · doi:10.1212/wnl.41.5_suppl_2.73 · Cited by 64 · see citing works
Smoking and Parkinson's disease
Tzourio, C., Rocca, W. A., Breteler, M. M. B., Baldereschi, M., Dartigues, J.-F., Pousa, S. L., Manubens-Bertran, J. M., Alpérovitch, A., & the EUROPARKINSON Study Group (1997) · Neurology · doi:10.1212/wnl.49.5.1267 · Cited by 62 · see citing works
Morens, D. M., Grandinetti, A., Davis, J. W., Ross, G. W., White, L. R., & REED, D. M. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008941 · Cited by 60 · see citing works
Barr, C., Wigg, K., Wu, J., Zai, C., Bloom, S., Tannock, R., Roberts, W., Malone, M., Schachar, R., & Kennedy, J. L. (2000) · American journal of medical genetics · doi:10.1002/(sici)1096-8628(20000207)96:1 · Cited by 53 · see citing works
Personality and Depression in Parkinson??s Disease
Hubble, J. P., VENKATESH, R., Hassanein, R. E. S., GRAY, C., & Roller, W. C. (1993) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199311000-00001 · Cited by 45 · see citing works
A Community Blood Pressure Survey: Rochester, Minnesota, 1986
Phillips, S. J., Whisnant, J. P., O’Fallon, W. M., & Hickman, R. D. (1988) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65531-1 · Cited by 40 · see citing works
Campion, M. E., Naessens, J. M., Leibson, C. L., Shaller, D., & Ballard, D. (1992) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60270-5 · Cited by 29 · see citing works
Ellenberg, J. H. (1994) · Neuroepidemiology · doi:10.1159/000110378 · Cited by 23 · see citing works
Correlation of Parkinson's disease severity and duration with123I-FP-CIT SPECT striatal uptake
Benamer, H. T. S., Patterson, J., Wyper, D. J., Hadley, D. M., Macphee, G. J. A., & Grosset, D. G. (2000) · Movement Disorders · doi:10.1002/1531-8257(200007)15:4
Flagged first, then by citations
Cited by
Sorted by citations
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110 · see citing works
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199 · see citing works
A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease
Hernán, M. A., Takkouche, B., Caamaño‐Isorna, F., & Gestal‐Otero, J. J. (2002) · Annals of Neurology · doi:10.1002/ana.10277 · Cited by 818 · see citing works
Rocca, W. A., Yawn, B. P., Sauver, J. L. S., Grossardt, B. R., & Melton, L. J. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.08.012 · Cited by 791 · see citing works
Prospective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women
Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001) · Annals of Neurology · doi:10.1002/ana.1052 · Cited by 677 · see citing works
Chen, J., Xu, K., Petzer, J. P., Staal, R. G. W., Xu, Y., Beilstein, M. A., Sonsalla, P. K., Castagnoli, K., Castagnoli, N. J., & Schwarzschild, M. A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-10-j0001.2001 · Cited by 608 · see citing works
Parkinson’s Disease: Etiology, Neuropathology, and Pathogenesis
Kouli, A., Torsney, K., & Kuan, W. (2018) · Codon Publications eBooks · doi:10.15586/codonpublications.parkinsonsdisease.2018.ch1 · Cited by 556 · see citing works
Neurodegenerative Diseases: An Overview of Environmental Risk Factors
Brown, R. C., Lockwood, A. H., & Sonawane, B. R. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7567 · Cited by 514 · see citing works
Medical records documentation of constipation preceding Parkinson disease
Savica, R., Carlin, J. M., Grossardt, B. R., Bower, J. H., Ahlskog, J. E., Maraganore, D. M., Bharucha, A. E., & Rocca, W. A. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c34af5 · Cited by 431 · see citing works
Advances in the treatment of Parkinson's disease
Singh, N., Pillay, V., & Choonara, Y. E. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.009 · Cited by 396 · see citing works
Physical activity and the risk of Parkinson disease
Chen, H., Zhang, S. M., Schwarzschild, M. A., Hernán, M. A., & Ascherio, A. (2005) · Neurology · doi:10.1212/01.wnl.0000151960.28687.93 · Cited by 371 · see citing works
Pooled analysis of tobacco use and risk of Parkinson disease.
Ritz, B., Ascherio, A., Checkoway, H., Marder, K., Nelson, L., Rocca, W., Ross, G., Strickland, D., den Eeden, S. K. V., & Gorell, J. (2007) · Archives of Neurology · doi:10.1001/archneur.64.7.990 · Cited by 366 · see citing works
Checkoway, H., Powers, K. M., Smith‐Weller, T., Franklin, G. M., Longstreth, W. T., & Swanson, P. D. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.8.732 · Cited by 370 · see citing works
Environmental risk factors for Parkinson’s disease and parkinsonism: the Geoparkinson study
Dick, F. D., Palma, G. D., Ahmadi, A., SCOTT, N. W., Prescott, G. J., Bennett, J. B., Semple, S. E., Dick, F. D., Counsell, C. E., Mozzoni, P., et al. (2007) · Occupational and Environmental Medicine · doi:10.1136/oem.2006.027003 · Cited by 326 · see citing works
Genetics of Parkinson's disease and parkinsonism
Hardy, J., Cai, H., Cookson, M., Gwinn, K. A., & Singleton, A. (2006) · Annals of Neurology · doi:10.1002/ana.21022 · Cited by 306 · see citing works
Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease
Xu, K., Bastia, E., & Schwarzschild, M. A. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.10.007 · Cited by 244 · see citing works
Chen, J., Sonsalla, P. K., Pedata, F., Melani, A., Domenici, M. R., Popoli, P., Geiger, J. D., Lopes, L. V., & de Mendonça, A. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.09.002 · Cited by 238 · see citing works
Breckenridge, C. B., Berry, C. L., Chang, E. T., Sielken, R. L., & Mandel, J. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151841 · Cited by 239 · see citing works
Pesticide/Environmental Exposures and Parkinson's Disease in East Texas
Dhillon, A. S., Tarbutton, G. L., Levin, J. L., Plotkin, G. M., Lowry, L. K., Nalbone, J. T., & Shepherd, S. (2008) · Journal of Agromedicine · doi:10.1080/10599240801986215 · Cited by 238 · see citing works
Caffeine, postmenopausal estrogen, and risk of Parkinson’s disease
Ascherio, A., Chen, H., Schwarzschild, M. A., Zhang, S. M., Colditz, G. A., & Speizer, F. E. (2003) · Neurology · doi:10.1212/01.wnl.0000046523.05125.87 · Cited by 233 · see citing works
Ascherio, A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh312 · Cited by 232 · see citing works
Qi, H., & Li, S. (2013) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12123 · Cited by 234 · see citing works
Cunha, R. A., & Agostinho, P. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1408 · Cited by 233 · see citing works
The emerging role of nutrition in Parkinson's disease
Seidl, S. E., Santiago, J. A., Bilyk, H. T., & Potashkin, J. A. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00036 · Cited by 209 · see citing works
Caffeine protects against MPTP‐induced blood‐brain barrier dysfunction in mouse striatum
Chen, X., Lan, X., Roche, I., Liu, R., & Geiger, J. D. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05697.x · Cited by 189 · see citing works
Temporal relationship between cigarette smoking and risk of Parkinson disease
Thacker, E. L., O’Reilly, É. J., Weisskopf, M. G., Chen, H., Schwarzschild, M. A., McCullough, M. L., Calle, E. E., Thun, M. J., & Ascherio, A. (2007) · Neurology · doi:10.1212/01.wnl.0000256374.50227.4b · Cited by 193 · see citing works
Smoking and Parkinson's disease: Systematic review of prospective studies
Allam, M. F., Campbell, M. J., Albert Hofman, D., del Castillo, A. S., & Navajas, R. F. (2004) · Movement Disorders · doi:10.1002/mds.20029 · Cited by 191 · see citing works
Occupational and environmental risk factors for Parkinson's disease
Lai, B. C. L., Marion, S. A., Teschke, K., & Tsui, J. K. C. (2002) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(01)00054-2 · Cited by 189 · see citing works
Enhanced Phosphatase Activity Attenuates α-Synucleinopathy in a Mouse Model
Lee, K.-W., Chen, W. W., Junn, E., Im, J., Grosso, H., Sonsalla, P. K., Feng, X., Ray, N., Fernandez, J. R., Chao, Y., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6513-10.2011 · Cited by 184 · see citing works
Monteiro, J., Alves, M. G., Oliveira, P. F., & Silva, B. M. (2016) · Molecules · doi:10.3390/molecules21080974 · Cited by 189 · see citing works
Prospective study of coffee consumption and risk of Parkinson’s disease
Sääksjärvi, K., Knekt, P., Rissanen, H., Laaksonen, M. A., Reunanen, A., & Männistö, S. (2008) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602788 · Cited by 182 · see citing works
Smoking and Parkinson’s disease in twins
Tanner, C. M., Goldman, S. M., Aston, D. A., Ottman, R., Ellenberg, J. H., Mayeux, R. P., & Langston, J. W. (2002) · Neurology · doi:10.1212/wnl.58.4.581 · Cited by 182 · see citing works
Survival Study of Parkinson Disease in Olmsted County, Minnesota
Elbaz, A., Bower, J. H., Peterson, B. J., Maraganore, D. M., McDonnell, S. K., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.1.91 · Cited by 179 · see citing works
A Perception on Health Benefits of Coffee
George, S. E., Ramalakshmi, K., & Rao, L. J. M. (2008) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390701522445 · Cited by 172 · see citing works
Caffeinated clues and the promise of adenosine A2Aantagonists in PD
Schwarzschild, M. A., Chen, J., & Ascherio, A. (2002) · Neurology · doi:10.1212/wnl.58.8.1154 · Cited by 161 · see citing works
Nicotine and Parkinson's disease: implications for therapy
Quik, M., O'Leary, K., & Tanner, C. M. (2008) · Movement Disorders · doi:10.1002/mds.21900 · Cited by 154 · see citing works
The Role of Early Life Environmental Risk Factors in Parkinson Disease: What Is the Evidence?
Logroscino, G. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7573 · Cited by 151 · see citing works
Education and occupations preceding Parkinson disease
Frigerio, R., Elbaz, A., Sanft, K. R., Peterson, B. J., Bower, J. H., Ahlskog, J. E., Grossardt, B. R., de Andrade, M., Maraganore, D. M., & Rocca, W. A. (2005) · Neurology · doi:10.1212/01.wnl.0000184520.21744.a2 · Cited by 149 · see citing works
What is the evidence for a premorbid parkinsonian personality: A systematic review
Ishihara, L., & Brayne, C. (2006) · Movement Disorders · doi:10.1002/mds.20980 · Cited by 147 · see citing works
Diet and Parkinson's disease: A potential role of dairy products in men
Chen, H., Zhang, S. M., Hernán, M. Á., Willett, W. C., & Ascherio, A. (2002) · Annals of Neurology · doi:10.1002/ana.10381 · Cited by 146 · see citing works
Muscarinic and Nicotinic Cholinergic Mechanisms in the Mesostriatal Dopamine Systems
Zhou, F.-M., Wilson, C. J., & Dani, J. A. (2003) · The Neuroscientist · doi:10.1177/1073858402239588 · Cited by 142 · see citing works
Xu, K., Xu, Y., Brown-Jermyn, D., Chen, J., Ascherio, A., Dluzen, D. E., & Schwarzschild, M. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3008-05.2006 · Cited by 142 · see citing works
Herraiz, T., & Chaparro, C. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.074 · Cited by 141 · see citing works
Dietary and lifestyle variables in relation to incidence of Parkinson’s disease in Greece
Kyrozis, A., Ghika, A., Stathopoulos, P., Vassilopoulos, D., Trichopoulos, D., & Trichopoulou, A. (2013) · European Journal of Epidemiology · doi:10.1007/s10654-012-9760-0 · Cited by 136 · see citing works
The Unique Regulation of Brain Cytochrome P450 2 (CYP2) Family Enzymes by Drugs and Genetics
Miksys, S. L., & Tyndale, R. F. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-120034149 · Cited by 135 · see citing works
Chen, X., Ghribi, O., & Geiger, J. D. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1376 · Cited by 133 · see citing works
Xu, K., Xu, Y.-H., Chen, J., & Schwarzschild, M. A. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.02.020 · Cited by 132 · see citing works
Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease
Fumagalli, F., Racagni, G., & Riva, M. A. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500360 · Cited by 132 · see citing works
Epidemiology of Parkinson's disease
Kasten, M., Chade, A., & Tanner, C. M. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83006-5 · Cited by 130 · see citing works
Comorbid conditions associated with Parkinson's disease: A population‐based study
Leibson, C. L., Maraganore, D. M., Bower, J. H., Ransom, J. E., O’Brien, P. C., & Rocca, W. A. (2005) · Movement Disorders · doi:10.1002/mds.20685 · Cited by 128 · see citing works
The Etiopathogenesis of Parkinson Disease and Suggestions for Future Research. Part I
Litvan, I., Halliday, G. M., Hallett, M., Goetz, C. G., Rocca, W. A., Duyckaerts, C. J., Ben‐Shlomo, Y., Dickson, D. W., Lang, A. E., Chesselet, M., et al. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3180415e42 · Cited by 122 · see citing works
Jee, H. J., Lee, S. G., Bormate, K. J., & Jung, Y.-S. (2020) · Nutrients · doi:10.3390/nu12103080 · Cited by 111 · see citing works
Xu, K., Xu, Y., Chen, J., & Schwarzschild, M. A. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00069-1 · Cited by 105 · see citing works
Nicotine from cigarette smoking and diet and Parkinson disease: a review
Ma, C., Liu, Y., Neumann, S., & Gao, X. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0090-8 · Cited by 101 · see citing works
Smoking and tea consumption delay onset of Parkinson's disease
Kandinov, B., Giladi, N., & Korczyn, A. D. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.02.011 · Cited by 99 · see citing works
Pharmacological potential of methylxanthines: Retrospective analysis and future expectations
Monteiro, J., Alves, M. G., Oliveira, P. F., & Silva, B. M. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1461607 · Cited by 103 · see citing works
Brakedal, B., Toker, L., Haugarvoll, K., & Tzoulis, C. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00280-4 · Cited by 98 · see citing works
Alcohol intake and risk of Parkinson's disease: A meta‐analysis of observational studies
Zhang, D., Jiang, H. F., & Xie, J. (2014) · Movement Disorders · doi:10.1002/mds.25863 · Cited by 96 · see citing works
Savica, R., Grossardt, B. R., Bower, J. H., Ahlskog, J. E., Boeve, B. F., Graff‐Radford, J., Rocca, W. A., & Mielke, M. M. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.0603 · Cited by 97 · see citing works
Liu, B., & Dluzen, D. E. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04616.x · Cited by 95 · see citing works
Effects of acute caffeine administration on adolescents
Temple, J. L., Dewey, A. M., & Briatico, L. N. (2010) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0021651 · Cited by 94 · see citing works
A Case-Control Study on Cigarette, Alcohol, and Coffee Consumption Preceding Parkinson’s Disease
Ragonese, P., Salemi, G., Morgante, F., Aridon, P., Epifanio, A., Buffa, D. J., Scoppa, F., & Savettieri, G. (2003) · Neuroepidemiology · doi:10.1159/000071193 · Cited by 96 · see citing works
Pathophysiological roles for purines
Morelli, M., Carta, A. R., Kachroo, A., & Schwarzschild, M. A. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)83010-9 · Cited by 94 · see citing works
Yan, R., Zhang, J., Park, H.-J., Park, E. S., Oh, S. E., Zheng, H., Junn, E., Voronkov, M. V., Stock, J. B., & Mouradian, M. M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1813365115 · Cited by 87 · see citing works
Alcohol consumption and the incidence of Parkinson's disease
Hernán, M. Á., Chen, H., Schwarzschild, M. A., & Ascherio, A. (2003) · Annals of Neurology · doi:10.1002/ana.10611 · Cited by 87 · see citing works
Kip, E., & Parr‐Brownlie, L. C. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101618 · Cited by 88 · see citing works
Intake of Japanese and Chinese teas reduces risk of Parkinson’s disease
Tanaka, K., Miyake, Y., Fukushima, W., Sasaki, S., Kiyohara, C., Tsuboi, Y., Yamada, T., Oeda, T., Miki, T., Kawamura, N., et al. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.02.016 · Cited by 76 · see citing works
Sutphin, G. L., Bishop, E., Yanos, M. E., Moller, R. M., & Kaeberlein, M. R. (2012) · Longevity & Healthspan · doi:10.1186/2046-2395-1-9 · Cited by 75 · see citing works
Fukutomi, R., Ohishi, T., Koyama, Y., Pervin, M., Nakamura, Y., & Isemura, M. (2021) · Molecules · doi:10.3390/molecules26020415 · Cited by 73 · see citing works
Alcohol in essential tremor and other movement disorders
Mostile, G., & Jankovic, J. J. (2010) · Movement Disorders · doi:10.1002/mds.23240 · Cited by 73 · see citing works
Risk factors for Parkinson's disease may differ in men and women: an exploratory study
Savica, R., Grossardt, B. R., Bower, J. H., Ahlskog, J. E., & Rocca, W. A. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.05.013 · Cited by 72 · see citing works
Autotoxicity, methylation and a road to the prevention of Parkinson’s disease
Williams, A. C., & Ramsden, D. B. (2004) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2004.10.002 · Cited by 65 · see citing works
Alcohol and risk of Parkinson's disease in a large, prospective cohort of men and women
Palacios, N., Gao, X., O’Reilly, É. J., Schwarzschild, M. A., McCullough, M. L., Mayo, T. L., Gapstur, S. M., & Ascherio, A. (2012) · Movement Disorders · doi:10.1002/mds.25050 · Cited by 63 · see citing works
Wierzejska, R. E. (2017) · Archives of Medical Science · doi:10.5114/aoms.2016.63599 · Cited by 62 · see citing works
Parkinsonism and Related Disorders
Slow, E., & Lang, A. E. (2019) · DeckerMed Transitional Year Weekly Curriculum™ · doi:10.2310/tywc.1178 · Cited by 62 · see citing works
Nicotinamide: A double edged sword
Williams, A. C., & Ramsden, D. B. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.05.011 · Cited by 61 · see citing works
Parkinson's Disease and Tea: A Quantitative Review
Quintana, J. L. B., Allam, M. F., del Castillo, A. S., & Navajas, R. F. (2009) · Journal of the American College of Nutrition · doi:10.1080/07315724.2009.10719754 · Cited by 61 · see citing works
Smokeless tobacco use and the risk of Parkinson's disease mortality
O’Reilly, É. J., McCullough, M. L., Chao, A., Henley, S. J., Calle, E. E., Thun, M. J., & Ascherio, A. (2005) · Movement Disorders · doi:10.1002/mds.20587 · Cited by 61 · see citing works
Family-based case-control study of cigarette smoking and Parkinson disease
Scott, W. K., Zhang, F., Stajich, J. M., Scott, B. L., Stacy, M. A., & Vance, J. M. (2005) · Neurology · doi:10.1212/01.wnl.0000150905.93241.b2 · Cited by 61 · see citing works
Association Between Parkinson’s Disease and Melanoma: Putting the Pieces Together
Ye, Q., Wen, Y., Al-Kuwari, N., & Chen, X. M. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00060 · Cited by 60 · see citing works
Alcohol consumption and risk for Parkinson’s disease: a systematic review and meta-analysis
Jiménez‐Jiménez, F. J., Alonso‐Navarro, H., García‐Martín, E., & Agúndez, J. A. G. (2018) · Journal of Neurology · doi:10.1007/s00415-018-9032-3 · Cited by 60 · see citing works
Siderowf, A. D., Jennings, D. L., Connolly, J., Doty, R. L., MAREK, K. L., & Stern, M. B. (2007) · Movement Disorders · doi:10.1002/mds.21707 · Cited by 60 · see citing works
Predictors of punding in Parkinson's disease: Results from a questionnaire survey
Lawrence, A. J., Blackwell, A. D., Barker, R. A., Spagnolo, F., Clark, L., Aitken, M. R. F., & Sahakian, B. J. (2007) · Movement Disorders · doi:10.1002/mds.21702 · Cited by 59 · see citing works
Adenosine A2A Receptor Antagonists for Parkinson???s Disease
Hauser, R. A., & Schwarzschild, M. A. (2005) · Drugs & Aging · doi:10.2165/00002512-200522060-00002 · Cited by 58 · see citing works
A prospective study of alcoholism and the risk of Parkinson?s disease
Hernán, M. Á., Logroscino, G., & guez, L. A. G. A. R. (2004) · Journal of Neurology · doi:10.1007/s00415-004-1705-4 · Cited by 58 · see citing works
Metabolic markers or conditions preceding Parkinson's disease: A case‐control study
Savica, R., Grossardt, B. R., Ahlskog, J. E., & Rocca, W. A. (2012) · Movement Disorders · doi:10.1002/mds.25016 · Cited by 57 · see citing works
Levy, G., Tang, M., COTE, L. J., Louis, E. D., Alfaro, B., Mejia‐Santana, H., Stern, Y., & Marder, K. S. (2002) · Movement Disorders · doi:10.1002/mds.10086 · Cited by 57 · see citing works
Impulse-Control Disorders in Parkinson's Disease
Ferrara, J. M., & Stacy, M. A. (2008) · CNS Spectrums · doi:10.1017/s1092852900013778 · Cited by 57 · see citing works
Behl, T., Madaan, P., Sehgal, A., Singh, S., Sharma, N., Bhatia, S., Al‐Harrasi, A., Chigurupati, S., Alrashdi, I., & BUNGAU, S. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810161 · Cited by 56 · see citing works
The role of nutrition on Parkinson’s disease: a systematic review
Bianchi, V. E., Rizzi, L., & Somaa, F. A. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2022.2073107 · Cited by 57 · see citing works
Smoking and Parkinson's Disease: Using Parental Smoking as a Proxy to Explore Causality
O'Reilly, E. J., Chen, H., Gardener, H. E., Gao, X., Schwarzschild, M. A., & Ascherio, A. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwn388 · Cited by 55 · see citing works
Caffeine in Parkinson's disease: A pilot open‐label, dose‐escalation study
Altman, R., Lang, A. E., & Postuma, R. B. (2011) · Movement Disorders · doi:10.1002/mds.23873 · Cited by 53 · see citing works
Bearn, J., Evans, A. H., Kelleher, M., Turner, K., & Lees, A. J. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.06.005 · Cited by 52 · see citing works
Parkinson's disease: the first common neurological disease due to auto-intoxication?
Williams, A. C., Cartwright, L. S., & Ramsden, D. B. (2005) · QJM · doi:10.1093/qjmed/hci027 · Cited by 52 · see citing works
Palacios, N., Weisskopf, M. G., Simon, K., Gao, X., Schwarzschild, M. A., & Ascherio, A. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.02.012 · Cited by 51 · see citing works
Therapies for Parkinson’s diseases: alternatives to current pharmacological interventions
Li, S., Dong, J., Cheng, C., & Le, W. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1603-9 · Cited by 50 · see citing works
Kudlacek, O., Just, H., Korkhov, V. M., Vartian, N., Klinger, M., Pankevych, H., Yang, Q., Nanoff, C., Freissmuth, M., & Boehm, S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300181 · Cited by 50 · see citing works
Risk factors of multiple system atrophy: A case‐control study in French patients
Vidal, J., Vidailhet, M., Elbaz, A., Derkinderen, P., Tzourio, C., & Alpérovitch, A. (2008) · Movement Disorders · doi:10.1002/mds.21857 · Cited by 47 · see citing works
Perimenopausal risk factors and future health
The ESHRE Capri Workshop Group (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr020 · Cited by 47 · see citing works
Galanaud, J. ‐., Elbaz, A., Clavel, J., Vidal, J., Corrèze, J., Alpérovitch, A., & Tzourio, C. (2004) · Movement Disorders · doi:10.1002/mds.20307 · Cited by 47 · see citing works
- Authors
- Benedetti, M. D., Bower, J. H., Maraganore, D. M., McDonnell, S. K., Peterson, B. J., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A.
- Affiliations
- Mayo Clinic (US)
- Venue
- Neurology
- Published
- 2000-11-14
- Volume
- 55
- Issue
- 9
- Pages
- 1350-1358
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2172189733
- Cited by
- 234
- References
- 34
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 5 · 2023: 6 · 2022: 8 · 2021: 10 · 2020: 5 · 2019: 5 · 2018: 9 · 2017: 9 · 2016: 9 · 2015: 6 · 2014: 7 · 2013: 7 · 2012: 10
- FWCI
- 5.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS033978, NS33978)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR030582, AR30582)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Pharmacology › Coffee research and impacts
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Parkinson's disease, coffee consumption, cigarette smoking, alcohol consumption, risk factors, age of onset, tobacco chewing, snuff use, alcoholism, Rochester Epidemiology Project, Rochester, Minnesota
- MeSH terms
- Adult, Aged, Alcohol Drinking, Coffee, Female, Humans, Male, Middle Aged, Minnesota, Parkinson Disease, Smoking, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
